Market cap
$20.5m
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Operating cash flow flipped positive and H2 turned profitable, yet the cash balance fell $4.2m versus only $0.1m of OCF — a reconciliation gap that
Revenue context before the current result.
Operating cash flow across covered periods.
Statutory profit after tax across covered periods.
Borrowings less cash across covered periods.
Market context
A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.
The latest close and share count context for the market price.
Market cap
$20.5m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
29.24x
Recent market cap compared with trailing earnings.
EPS
0.00
Recent filing-derived earnings per share.
PEG
Not available
Not meaningful without positive comparable earnings growth.
EV/EBITDA
Not available
Not available for this company right now.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
1.57x
Market value compared with latest reported equity.
Yield and fund-style valuation where the company shape supports it.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY23 vs FY22
Revenue
$10.2m
+14.2% ↑ vs $9m
EBITDA
—
— vs −$2.1m
Net profit after tax
−$1.3m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
$0.11m
+104.6% ↑ vs −$2.3m
Declared dividend per share
0.0c
flat vs 0.0c
Profit before tax
−$1.3m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$4.3m
-49.9% ↓ vs $8.5m
Total assets
$12.8m
-9.4% ↓ vs $14.1m
Analysis ofBLT FY23Result releasedAnnolyse analysis published
What changed
Operating cash flow flipped from an outflow of $2.3m to a small inflow of $0.1m, and the FY22 EBITDA loss of $2.1m is no longer disclosed on a comparable basis in the supplied excerpts.
The second-half shape is the more important movement within the year. With HY23 NPAT of -$1.7m and full-year NPAT of -$1.4m, the implied H2 NPAT was approximately +$0.3m, consistent with the release headline of "a profitable second half year."
Despite the OCF flip, cash and equivalents fell from $8.5m to $4.3m, a 49.9% decline. Equity fell 10.8% to $10.8m, gross borrowings went to zero, and the balance sheet remains net cash by $4.3m.
What matters
Reported OCF was +$0.1m and capex was only -$0.1m, producing pre-lease free cash flow of about +$0.06m. Yet cash fell by $4.2m. The supplied data does not reconcile the gap, which means the on-paper return to operating cash generation overstates the period's actual liquidity outcome. For a company with $4.3m of cash and no revolver disclosed, that gap is the dominant question on the result.
The H2 inflection is real but small. An implied H2 NPAT of roughly +$0.3m is the first profitable half since the strategy reset announced in July 2022, and it is driven by both higher revenue ($5.9m implied in H2 versus $4.3m in H1) and the lower cost base flagged in management commentary. This matters because it is the first evidence the B2B-and-partnerships strategy can clear breakeven, but the half is too small to demonstrate that profitability is sustainable rather than timing-assisted.
Working capital tightened modestly. Receivable days fell from 68.8 to 51.6 and inventory days from 31.8 to 26.2, releasing roughly $0.3m of operating working capital. That helped OCF but is not a repeatable lever — debtor and inventory balances are now low in absolute terms, so further cash release from this source is limited.
Expectations
The H2 profitability and the 14.2% revenue growth are directionally consistent with that goal.
The second-half-weighted shape (HY23 contributed only 41.9% of full-year revenue) is a meaningful read for FY24: it sets a higher exit run-rate but also means that any softening in the H2 partner-driven revenue would land disproportionately. Without disclosed forward work or partner contract terms, the durability of the H2 step-up cannot be assessed from this release.
Quality of result
Non-recurring items are not flagged. To that extent, the 50.1% loss reduction reflects genuine operating progress, supported by 14.2% revenue growth and lower opex implied by the EBITDA-loss to small-NPAT-loss compression.
The cash quality is materially weaker than the P&L quality. FCF-to-NPAT of -4.1% understates the issue, because the cash balance fell $4.2m while pre-lease FCF was only +$0.06m. Possible drains — lease payments, term-deposit reclassifications, or other investing/financing flows — are not surfaced in the supplied excerpts. Until that bridge is explained, the H2 profitability print should be treated as an early signal rather than confirmation that the business is self-funding.
Unresolved
This briefing cannot assess the cash bridge between reported OCF and the $4.2m fall in cash and equivalents, which is the single most important quality question on the result.
Chat
Ask follow-up questions about Blis Technologies's FY23 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
BLIS Annual Report FY23
FY23 / financial reportFinancial Results Announcement
FY23 / results announcementFinancial Results Announcement
FY22 / results announcementFinancial Results Announcement
FY22 / results releaseFY22 Annual Report
FY22 / financial reportFinancial results announcement
HY23 / results announcementFinancial results announcement
HY23 / results releaseHalf year report 30 September 2022
HY23 / financial reportRelated insights
Cross-company views selected from the metrics in this briefing.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 0.0%.
Revenue growth context
Revenue growth was 14.2% for this reporting period.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 0.0pp.
Working-capital pressure
Inventory days were 26 days, -6 days versus the prior comparable period.
Get the next Blis Technologies briefing and related NZX reporting-season updates by email.